* Outset Medical Inc OM.OQ OM.O is expected to show a
rise in
quarterly revenue when it reports results on May 3.
* The San Jose California-based company is expected to
report a
4.0% increase in revenue to $31.759 million from $30.55 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. The company's guidance on February 13
2023, for the period ended March 31, was for revenue of $32.007
million.
* Refinitiv's mean analyst estimate for Outset Medical Inc
is for
a loss of 74 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Outset
Medical
Inc is $32, above its last closing price of $19.08.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 -0.91 -0.86 -0.86 Met 0
Sep. 30 2022 -0.84 -0.81 -0.85 Missed -4.9
Jun. 30 2022 -0.68 -0.70 -0.92 Missed -31.8
Mar. 31 2022 -0.71 -0.72 -0.78 Missed -8.3
Dec. -0.75 -0.77 -0.87 Missed -13.4
31 2021
Sep. 30 2021 -0.77 -0.73 -0.65 Beat 11
Jun. 30 2021 -0.69 -0.70 -0.66 Beat 5.4
Mar. 31 2021 -0.80 -0.81 -0.70 Beat 13.7
This summary was machine generated May 2 at 01:30 GMT. All
figures in US dollars unless otherwise stated